Pseudogenization of the MCP-2/CCL8 chemokine gene in European rabbit (genus Oryctolagus), but not in species of Cottontail rabbit (Sylvilagus) and Hare (Lepus)

BMC Genetics

Pedro J Esteves²  Joana Abrantes³  Ana Lemos de Matos¹  Sandra Afonso¹  Wessel van der Loo⁴ 

[1] Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, 60153, USA;Centro de Investigação em Tecnologias da Saúde, IPSN, CESPU, Gandra, 4585-116, Portugal;INSERM U892 - Institut de Biologie Equipe 5, Nantes, Cedex 01, 44007, France;Departamento de Zoologia e Antropologia, Faculdade de Ciências, Universidade do Porto, Porto, 4169-007, Portugal

关键词: Lepus;    Sylvilagus;    Bunolagus;    Oryctolagus;    Myxomatosis;    Poxvirus;    Pseudogene;    Monocyte chemotactic protein;    Chemokines;   

Others  :  1121379
DOI  :  10.1186/1471-2156-13-72

 received in 2012-02-06, accepted in 2012-07-11,  发布年份 2012

【 摘 要 】

Background

Recent studies in human have highlighted the importance of the monocyte chemotactic proteins (MCP) in leukocyte trafficking and their effects in inflammatory processes, tumor progression, and HIV-1 infection. In European rabbit (Oryctolagus cuniculus) one of the prime MCP targets, the chemokine receptor CCR5 underwent a unique structural alteration. Until now, no homologue of MCP-2/CCL8^a, MCP-3/CCL7 or MCP-4/CCL13 genes have been reported for this species. This is interesting, because at least the first two genes are expressed in most, if not all, mammals studied, and appear to be implicated in a variety of important chemokine ligand-receptor interactions. By assessing the Rabbit Whole Genome Sequence (WGS) data we have searched for orthologs of the mammalian genes of the MCP-Eotaxin cluster.

Results

We have localized the orthologs of these chemokine genes in the genome of European rabbit and compared them to those of leporid genera which do (i.e. Oryctolagus and Bunolagus) or do not share the CCR5 alteration with European rabbit (i.e. Lepus and Sylvilagus). Of the Rabbit orthologs of the CCL8, CCL7, and CCL13 genes only the last two were potentially functional, although showing some structural anomalies at the protein level. The ortholog of MCP-2/CCL8 appeared to be pseudogenized by deleterious nucleotide substitutions affecting exon1 and exon2. By analyzing both genomic and cDNA products, these studies were extended to wild specimens of four genera of the Leporidae family: Oryctolagus, Bunolagus, Lepus, and Sylvilagus. It appeared that the anomalies of the MCP-3/CCL7 and MCP-4/CCL13 proteins are shared among the different species of leporids. In contrast, whereas MCP-2/CCL8 was pseudogenized in every studied specimen of the Oryctolagus - Bunolagus lineage, this gene was intact in species of the Lepus - Sylvilagus lineage, and was, at least in Lepus, correctly transcribed.

Conclusion

The biological function of a gene was often revealed in situations of dysfunction or gene loss. Infections with Myxoma virus (MYXV) tend to be fatal in European rabbit (genus Oryctolagus), while being harmless in Hares (genus Lepus) and benign in Cottontail rabbit (genus Sylvilagus), the natural hosts of the virus. This communication should stimulate research on a possible role of MCP-2/CCL8 in poxvirus related pathogenicity.

【 授权许可】

   
2012 van der Loo et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

【 参考文献 】

• [1]Lopez-Martinez N: Revision sistematica y biostratigrafica de los lagomorphos (Mammalia) del neogeno y cuaternario de España. Disputacion General de Aragon: Memorias del Museo Paleontologico de la Universidad de Zaragoza; 1989.
• [2]Chapman JA, Flux JEC: Rabbits, hares and pikas: status survey and conservation action plan. IUCN/SSC Lagomorph Specialist Group (ed.). Oxford UK: Information Press; 1990.
• [3]Rougeot J: Origin et histoire du lapin. Ethnozootechnie 1981, 27:1-9.
• [4]Flux JEC: World distribution. In The European rabbit: The history of a successful colonizer. Edited by Thomson HV, King CM. Oxford: Oxford Science Publications; 1994:8-21.
• [5]Callou C: Modifications de l'aire de répartition du Lapin (Oryctolagus cuniculus) en France et en Espagne, du Pléistocène à l'époque actuelle État de la question. Anthropozoologica 1995, 21:95-114.
• [6]Monnerot M, Vigne JD, Biju-Duval C, Casane D, Callou C, Hardy C, Mougel F, Soriguer R, Dennebouy N, Mounolou JC: Rabbit and man: genetic and historic approach. Genet Sel Evol 1994, 26:167-187. BioMed Central Full Text
• [7]Fenner F: Myxomatosis. Br Med Bull 1959, 15:240-245.
• [8]Hyde RR, Gardner E: Infectious myxoma of rabbits. Am J Epidemiol 1933, 17:446-46.
• [9]Regnery DC, Marshall ID: Studies in the epidemiology of myxomatosis in California IV: the susceptibility of six leporid species to Californian myxoma virus and the relative infectivity of their tumors for mosquitoes. Am J Epidemiol 1971, 94:508-513.
• [10]Best SM, Collins SV, Kerr PJ: Coevolution of host and virus: cellular localization of virus in myxoma virus infection of resistant and susceptible European rabbits. Virology 2000, 277:76-91.
• [11]Zúñiga MC: Lessons in détente or know thy host: the immunomodulatory gene products of myxoma virus. J Biosci 2003, 28:273-285.
• [12]Stanford MM, Werden SJ, McFadden G: Myxoma virus in the European rabbit: interactions between the virus and its susceptible host. Vet Res 2007, 38:299-318.
• [13]McFadden G, Graham K, Ellison K, Barry M, Macen J, Schreiber M, Mossman K, Nash P, Lalani A, Everett H: Interruption of cytokine networks by poxviruses: lessons from myxoma virus. J Leukoc Biol 1995, 57:731-738.
• [14]Ransohoff RM: Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity 2009, 31:711-721.
• [15]Liu J, Wennier S, McFadden G: The immunoregulatory properties of oncolytic myxoma virus and their implications in therapeutics. Microbes Infect 2010, 12:1144-1152.
• [16]Spiesschaert B, McFadden G, Hermans K, Hans Nauwynck H, Van de Walle GR: The current status and future directions of myxoma virus, a master in immune evasion. Vet Res 2011, 42:76:1–18.
• [17]Lalani AS, Masters J, Zeng W, Barrett J, Pannu R, Everett H, Arendt CW, McFadden G: Use of chemokine receptors by poxviruses. Science 1999, 286:1968-1971.
• [18]Masters J, Hinek AA, Uddin S, Platanias LC, Zeng W, McFadden G, Fish EN: Poxvirus infection rapidly activates tyrosine kinase signal transduction. J Biol Chem 2001, 276:48371-48375.
• [19]Johnston JB, Johnston JB, Barrett JW, Chang W, Chung CS, Zeng W, Masters J, Mann M, Wang G, McFadden G: Role of serine-threonine kinase PAK-1 in Myxoma virus replication. J Virol 2003, 77:5877-5888.
• [20]Carmo CR, Esteves PJ, Ferrand N, van der Loo W: Genetic variation at chemokine receptor CCR5 in leporids: alteration at the 2nd extracellular domain by gene conversion with CCR2 in Oryctolagus, but not in Sylvilagus and Lepus species. Immunogenetics 2006, 58:494-501.
• [21]Abrantes J, Carmo CR, Matthee CA, Yamada F, van der Loo W, Esteves PJ: A shared unusual genetic change at the chemokine receptor type 5 between Oryctolagus, Bunolagus and Pentalagus. Conserv Genet 2011, 12:325-330.
• [22]Nomiyama H, Osada N, Yoshie O: The evolution of mammalian chemokine genes. Cytokine Growth Factor Rev 2010, 21:253-262.
• [23]Eli and Edythe L, Broad Institute of Harvard and MIT: Rabbit Genome Project. http://www.broadinstitute.org/scientific-community/science/projects/mammals-models/rabbit/rabbit-genome-project webcite
• [24]Howard MZ, Galligan CL: An expanding appreciation of the role chemokine receptors play in cancer progression. Curr Pharm Des 2004, 10:2377-2389.
• [25]Loetscher P, Seitz M, Clark-Lewis I, Baggiolini M, Moser B: Monocyte chemotactic proteins MCP-1, MCP-2, and MCP-3 are major attractants for human CD4+ and CD8+ T lymphocytes. FASEB J 1994, 8:1055-1106.
• [26]Van Coillie E, Proost P, Van Aelst I, Struyf S, Polfliet M, De Meester I, Harvey DJ, Van Damme J, Opdenakker G: Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by cd26/dipeptidyl peptidase IV. Biochemistry 1998, 37:12672-12680.
• [27]Hellier S, Frodsham AJ, Hennig BJW, Klenerman P, Knapp S, Ramaley P, Satsangi J, Wright M, Zhang L, Thomas HC, Thursz M, Hill AVS: Association of genetic variants of the chemokine receptor CCR5 and its ligands, RANTES and MCP-2, with outcome of HCV infection. Hepatology 2003, 38:1468-1476.
• [28]Struyf S, Proost P, Vandercappellen J, Dempe S, Noyens B, Nelissen S, Gouwy M, Locati M, Opdenakker G, Dinsart C: Synergistic up-regulation of MCP-2/CCL8 activity is counteracted by chemokine cleavage, limiting its inflammatory and anti-tumoral effects. Eur J Immunol 2009, 39:843-857.
• [29]Burge C, Karlin S: Prediction of complete gene structures in human genomic DNA. J Mol Biol 1997, 68:78-94. http://genes.mit.edu/GENSCAN.html webcite
• [30]Proost P, Wuyts A, Van Damme J: Human monocyte chemotactic proteins-2 and −3: structural and functional comparison with MCP-1. J Leukoc Biol 1996, 59:67-74.
• [31]Yamamoto N, Tanabe Y, Okamoto R, Dawson PE, Kajihara K: Chemical synthesis of a glycoprotein having an intact human complex-type sialyloligosaccharide under the Boc and Fmoc synthetic strategies. J Am Chem Soc 2008, 130:501-510.
• [32]Proost P, Struyf S, Wuyts A, Menten P, De Meester I, Lambeir AM, Scharpé S, Schols D, De Clercq E, Van Damme J: Isolation and identification of naturally modified C-C chemokinesMCP-1, MCP-2 and RANTES: effects of posttranslation modifications on receptor usage, chemotactic and anti-HIV-1 activity. Eur CytokineNetw 1998, 9:73-75.
• [33]Proost P, Struyf S, Couvreur M, Lenaerts JP, Conings R, Menten P, Verhaert P, Wuyts A, Van Damme J: Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2 (6–76) as a natural chemokine inhibitor. J Immunol 1998, 160:4034-4041.
• [34]McQuibban GA, Gong JH, Wong JP, Wallace JL, Clark-Lewis I, Overall M: Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 2002, 100:1160-1167.
• [35]Dean RA, Cox JH, Bellac CL, Doucet A, Starr AE, Overall CM: Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and −13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx. Blood 2008, 112:3455-3464.
• [36]Tamura K, Dudley J, Nei M, Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007, 24:1596-1599. http://www.megasoftware.net/ webcite
• [37]Blaszczyk J, Coillie EV, Proost P, Damme JV, Opdenakker G, Bujacz GD, Wang JM, Ji X: Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors. Biochemistry 2000, 39:14075-14081.
• [38]van der Loo W, Ferrand N, Soriguer RC: Estimation of gene diversity at the b locus of the constant region of the immunoglobulin light chain in natural populations of European rabbit (Oryctolagus cuniculus) in Portugal, Andalusia and on the Azorean Islands. Genetics 1991, 127:789-799.
• [39]Branco M, Ferrand N, Monnerot M: Phylogeography of the European rabbit (Oryctolagus cuniculus) in the Iberian Peninsula inferred from RFLP analysis of the cytochrome b gene. Heredity 2000, 85:307-317.
• [40]Biju-Duval C, Ennafaa H, Dennebouy N, Monnerot M, Mignotte F, Soriguer R, El Gaied A, El Hili A, Mounolou JC: Mitochondrial DNA evolution in lagomorphs: origin of systematic heteroplasmy and organization of diversity in European rabbits. J Molec Evol 1991, 33:92-102.
• [41]Geraldes A, Ferrand N, Nachman N: Contrasting patterns of introgression at X linked loci across the hybrid zone between subspecies of the European rabbit (Oryctolagus cuniculus). Genetics 2006, 173:919-933.
• [42]Matthee CA, van Vuuren BJ, Bell D, Robinson TJ: A molecular supermatrix of the rabbits and hares (Leporidae) allows for the identification of five intercontinental exchanges during the Miocene. Syst Biol 2004, 53:433-447.
• [43]Nguyen Hoang AT, Liu H, Juaréz J, Aziz N, Kaye PM, Svensson M: Stromal cell derived CXCL12 and CCL8 cooperate to support increased development of regulatory dendritic cells following Leishmania infection. J Immunol 2010, 185:2360-2371.
• [44]Islam SA, Chang DS, Colvin RA, Byrne MH, McCully ML, Moser B, Lira SA, Charo IF, Luster AD: Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ TH2 cells. Nat Immunol 2011, 12:167-177.
• [45]Moser B, Wolf M, Walz A, Loetscher P: Chemokines: multiple levels of leukocyte migration control. Trends Immunol 2004, 25:75-84.
• [46]D’Souza P, Harden V: Chemokines and HIV−1 second receptors. Nat Med 1996, 2:1293-1300.
• [47]Premack BA, Schall TJ: Chemokine receptors: gateways to inflammation and infection. Nat Med 1996, 2:1174-1178.
• [48]Blanpain C, Migeotte I, Lee B, Vakili J, Doranz BJ, Govaerts C, Vassart G, Doms RW, Parmentier M: CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. Blood 1999, 94:1899-1905.
• [49]Rom S, Rom I, Passiatore G, Pacifici M, Radhakrishnan S, Del Valle L, Piña-Oviedo S, Khalili K, Eletto D, Peruzzi F: CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells. FASEB J 2010, 24:2292-2300.
• [50]Krug MS, Berger SL: First strand cDNA synthesis primed with oligo (dT). Methods Enzymol 1987, 152:316-320.
• [51]Rozen S, Skaletsky HJ: Primer3 on the WWW for general users and for biologist programmers. In Bioinformatics Methods and Protocols: Methods in Molecular Biology. Edited by Krawetz S, Misener S. Totowa, NJ: Humana Press; 2000:365-386. http://www.ncbi.nlm.nih.gov/tools/primer blast webcite
• [52]Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW: GenBank®. Nucleic Acids Res 2011, 39:D32-D37.
• [53]Flicek P, Amode MR, Barrell D, Beal K, Brent S, Chen Y, Clapham P, Coates G, Fairley S, Fitzgerald S, Gordon L, Hendrix M, Hourlier T, Johnson N, Kähäri A, Keefe D, Keenan S, Kinsella R, Kokocinski F, Kulesha E, Larsson P, Longden I, McLaren W, Overduin B, Pritchard B, Riat HS, Rios D, Ritchie GR, Ruffier M, Schuster M, Sobral D, Spudich G, Tang YA, Trevanion S, Vandrovcova J, Vilella AJ, White S, Wilder SP, Zadissa A, Zamora J, Aken BL, Birney E, Cunningham F, Dunham I, Durbin R, Fernández-Suarez XM, Herrero J, Hubbard TJ, Parker A, Proctor G, Vogel J, Searle SM: Ensembl 2011. Nucl Acids Res 2011, 39(Database issue):D800-D806. http://www.ensembl.org/index.html webcite
• [54]Brudno M, Steinkamp R, Morgenstern B: The CHAOS/DIALIGN WWW server for multiple alignment of genomic sequences. Nucl Acids Res 2004, 32:W41-W44. http://dialign.gobics.de webcite
• [55]Hall T: Bioedit. v7th edition. 2011, 1-3. http://www.mbio.ncsu.edu/bioedit/bioedit.html webcite